Physician profile
Jae Eun Lee
NPI 1346622792
$17,896.21
in general payments reported to CMS, 2019-2025
57 companies · $3,400 in 2025
The $3,400 reported for 2025 was more than what 80% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $230 · 2021: $1,479 · 2022: $3,924 · 2023: $4,348 · 2024: $4,515 · 2025: $3,400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Education: $437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,825.60 |
| Education | $437.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $1,674.87 | 2021-2025 | Vumerity, Tysabri, Skyclarys |
| Abbvie INC. | $1,572.33 | 2021-2025 | |
| Ucb, INC. | $1,520.72 | 2022-2025 | Rystiggo, Briviact, Nayzilam |
| Pfizer INC. | $916.59 | 2023-2025 | |
| Neurocrine Biosciences, INC. | $835.75 | 2021-2025 | Ingrezza, Ongentys |
| Alexion Pharmaceuticals, INC. | $835.47 | 2021-2025 | Ultomiris, Soliris |
| Mdd US Operations, LLC | $694.36 | 2023-2025 | Gocovri, Gocovri |
| Emd Serono, INC. | $635.03 | 2019-2025 | Mavenclad, Mavenclad |
| Lilly USA, LLC | $541.44 | 2021-2025 | Kisunla, Emgality, Amyvid |
| Jazz Pharmaceuticals INC. | $496.77 | 2021-2025 | |
| Lundbeck LLC | $481.70 | 2021-2025 | Vyepti, Rexulti |
| Amgen INC. | $453.11 | 2021-2023 | Aimovig |
| Novartis Pharmaceuticals Corporation | $447.30 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $440.34 | 2021-2025 | Austedo Xr, Austedo, Austedo Xr |
| Neurelis, INC. | $425.48 | 2021-2025 | Valtoco |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $420.22 | 2021-2025 | Zeposia |
| Catalyst Pharmaceuticals, INC. | $395.04 | 2022-2025 | Fycompa, Firdapse |
| Biohaven Pharmaceutical Holding Company LTD. | $360.67 | 2022 | |
| Eisai INC. | $339.96 | 2021-2025 | |
| Csl Behring | $332.20 | 2022-2025 | Hizentra |
| Mallinckrodt Hospital Products INC. | $294.66 | 2021-2025 | Acthar |
| Genentech USA, INC. | $292.87 | 2022-2025 | Ocrevus, Ocrevus Zunovo, Enspryng |
| Amneal Pharmaceuticals LLC | $292.72 | 2021-2025 | Rytary, Crexont |
| Grifols USA, LLC | $264.81 | 2022-2025 | Gamunex-C |
| Sk Life Science, INC. | $255.81 | 2021-2024 | |
| Argenx US, INC. | $236.17 | 2022-2025 | Vyvgart |
| Vanda Pharmaceuticals INC. | $228.46 | 2025 | Ponvory |
| Otsuka America Pharmaceutical, INC. | $203.88 | 2023-2025 | Rexulti, Nuedexta |
| Sumitomo Pharma America, INC. | $162.76 | 2023-2024 | Aptiom |
| Octapharma USA, INC. | $157.26 | 2021-2024 | Panzyga |
| Janssen Pharmaceuticals, INC | $149.89 | 2021-2025 | Ponvory |
| Alnylam Pharmaceuticals INC. | $141.89 | 2021-2024 | Onpattro, Amvuttra |
| Acadia Pharmaceuticals INC | $134.88 | 2021-2023 | Nuplazid |
| Tg Therapeutics, INC. | $124.23 | 2023-2025 | |
| Janssen Biotech, INC. | $118.56 | 2025 | |
| Supernus Pharmaceuticals, INC. | $102.78 | 2022-2025 | Qelbree |
| Cycle Pharmaceuticals INC | $100.55 | 2024-2025 | Tascenso Odt, Bafiertam |
| Sunovion Pharmaceuticals INC. | $89.33 | 2022 | |
| Ani Pharmaceuticals, INC. | $84.30 | 2023-2025 | Purified Cortrophin Gel |
| Harmony Biosciences LLC | $69.04 | 2023-2025 | Wakix |
| Axsome Therapeutics, INC. | $64.44 | 2025 | Symbravo |
| Takeda Pharmaceuticals U.S.A., INC. | $63.54 | 2022-2025 | Hyqvia |
| Biohaven Pharmaceuticals, INC. | $63.15 | 2021 | |
| Collegium Pharmaceutical, INC. | $42.83 | 2022 | |
| Genzyme Corporation | $41.07 | 2024-2025 | |
| Tersera Therapeutics LLC | $40.06 | 2019 | |
| Zogenix INC. | $39.99 | 2021 | |
| Merck Sharp & Dohme LLC | $34.20 | 2024 | Welireg |
| Xeris Pharmaceuticals, INC. | $32.80 | 2025 | Keveyis |
| Arbor Pharmaceuticals, INC. | $27.46 | 2021 | |
| Ceribell, INC. | $21.00 | 2025 | Pocket Eeg Device |
| Ipsen Biopharmaceuticals, INC | $20.13 | 2025 | Dysport |
| Impel Pharmaceuticals INC. | $19.92 | 2023 | Trudhesa |
| Genentech, INC. | $18.85 | 2023 | Enspryng |
| Upsher-Smith Laboratories LLC | $16.42 | 2022 | |
| Tanabe Pharma America, INC. | $14.34 | 2022 | |
| Avion Pharmaceuticals | $11.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jae Eun Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.